These underlying mechanisms of resistin further explain that increased risk of cancer mortality seen among Blacks with higher baseline levels of resistin are partly due to the prevalence of comorbidities such as obesity and diabetes, however the observed association was statistically independent of these factors. This evidence concerns the gene RETN and obesity due to melanocortin 4 receptor deficiency.